Technology, Autos, Health · 7 days
185 storiesRussian anti-plague lab researcher dies; US and EU say they are monitoring
A 28-year-old female researcher at the Irkutsk anti-plague research institute in Shelekhov, Russia, died after being diagnosed with pneumonia of unknown cause, the state agency Rospotrebnadzor said. About 200 people who may have had contact…
AMD CEO Lisa Su to visit Korea Oct. 7 for Gamer Day; AI chip talks expected
AMD chair and CEO Lisa Su will visit Korea on Oct. 7, about seven months after her March trip, to attend an “AMD Gamer Day” event at 2 p.m. at Dragon City in Yongsan-gu, Seoul, AMD said. Su and senior vice president Jack Huynh will attend, …
Russia denies plague after worker at Siberian institute dies of unknown pneumonia
A woman who worked at a plague-control research institute in Russia's Irkutsk region in eastern Siberia has died; Japanese outlets differ on whether she died on Oct 1 or Oct 2. Russian authorities say the cause was “pneumonia of unknown cau…
Russia quarantines hospital as lab worker’s death puts nearly 200 under observation
A female employee of the Irkutsk Anti-Plague Research Institute of Siberia and the Far East died last week of pneumonia of unknown cause, Russian authorities said, and a hospital in the town of Shelekhov was placed under quarantine. Officia…
Hyundai launches 2027 Sonata The Edge with new Black N Line trim
Hyundai Motor launched the facelifted 2027 Sonata The Edge on Oct. 7, adding a Black N Line design trim based on the top Inspiration grade, with a black Hyundai emblem, black name lettering and 19-inch matte black wheels. The S trim gains a…
China medical insurance pooled funds take in 2.07 trillion yuan in Jan-Aug
China's National Healthcare Security Administration released data showing that in January to August 2026 the basic medical insurance (including maternity insurance) pooled funds took in 2.072772 trillion yuan and spent 1.550414 trillion yua…
Celltrion's Avtozma wins FDA nod for pediatric COVID-19 use in US
Celltrion said the US Food and Drug Administration granted an additional approval for its Avtozma (tocilizumab) intravenous formulation to treat COVID-19 in patients aged 2 and older. The approval widens the drug's COVID-19 indication from …
South Korea study links severe gestational diabetes to higher diabetes risk in children
South Korea's National Institute of Health said children of mothers who had gestational diabetes are more likely to develop diabetes, with the risk rising to 4.3 times for type 2 diabetes among children of mothers who needed insulin during …
Trump says he has call scheduled with Putin over suspected plague death in Siberia
President Trump said Tuesday he has a call scheduled with Vladimir Putin about the suspected pneumonic plague case in Siberia, after saying Monday the US was willing to help Russia. The case follows the death of Darya Shipilova, 28, a worke…
WHO says risk low as US presses Russia for transparency on plague lab death
The U.S. State Department is monitoring reports of a fatal case of suspected pneumonic plague in Irkutsk Oblast, Russia, and Secretary of State Marco Rubio has publicly called on Moscow to be more transparent about the death of a 28-year-ol…
BMW Korea electrified sales top 10,000, a first for a premium import brand
BMW Korea said it sold 10,335 electrified vehicles — battery-electric and plug-in hybrid — in the first nine months of the year, becoming the first premium import brand in Korea to pass 10,000. Battery-electric sales rose about 56% on the y…
WHO keeps low-risk view on Russian plague lab death; Russia denies accident
The World Health Organization said the public health risk to the general public appears low after a researcher at a plague research institute in Russia's Irkutsk region died following what reports described as a broken test tube of plague p…
New York declares measles disaster emergency as rural cases rise
New York Governor Kathy Hochul declared a statewide disaster emergency on Monday over a measles outbreak, an order CNN reported is the first such declaration by a U.S. state since cases began surging in 2025. The state has reported 108 case…
Suzuki to launch kei EV e SKY on Nov 16 from ¥2.12 million, Japan's cheapest kei EV
Suzuki said on Oct 6 that it will launch the e SKY, its first kei-class passenger electric vehicle, on Nov 16, with prices from ¥2.12 million including tax — the lowest for a kei EV in Japan, according to Nikkei, Asahi Shimbun and Yomiuri S…
Russian woman at plague research institute dies; cause disputed
A woman in her 20s who worked at a plague control research institute in Russia's Irkutsk region died on October 2. Russian health authorities said on October 4 the cause was “pneumonia of unknown origin,” while speculation of plague infecti…
WHO and Russia say no further plague infections after Siberian lab worker's death
A female worker at the Irkutsk Anti-Plague Institute of Siberia and the Far East died last week from pneumonia of undetermined origin, according to Russian authorities and the WHO. Russia's Rospotrebnadzor said 60% of the identified contact…
Kenya confirms first Ebola death after patient arrives from Congo via Uganda
Kenya’s Health Ministry confirmed the country’s first imported Ebola case on Tuesday, after a Kenyan man who arrived from the Democratic Republic of Congo via Uganda was treated at Nairobi Hospital and died late Monday. Authorities placed K…
Hoban Construction develops AI design tech to auto-apply per-unit buyer options
Hoban Construction said it developed AI-based design technology that automatically reflects apartment buyers’ option contract choices in each unit’s building information model (BIM). The technology was developed jointly with building and in…
National university hospital bed occupancy stuck at 56.4%, surgeries still below 2023
Average bed occupancy at South Korea's nine national university hospitals was 56.4% in both 2024 and last year, down from 73.6% in 2023, according to data Rep. Seo Mi-hwa obtained from the Ministry of Health and Welfare. Surgeries at ten na…
GC Cell starts Phase 1b trial of GCC2005 in T-cell lymphoma, first patient dosed
GC Cell said on Oct 7 that its drug candidate GCC2005 (CD5 CAR-NK), a cell therapy for T-cell lymphoma, has entered a Phase 1b trial and that the first subject has been dosed. The company completed the dose-escalation stage of Phase 1a and …